Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Overview of annual performance metrics for index funds highlights consistency and risk-adjusted returns to inform choices.
21,610 articlesBoxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
When a stock stalls, a disciplined fund can still see value in the long run. This article explains why this fund made...
X-Energy lands ratings from six major firms, with five Buy or Overweight calls and a top target of $57, as investors ...
Goldman Sachs raises Enphase Energy's price target to 57 and maintains a Buy rating, highlighting a nascent rebound i...
Vice President JD Vance publicly pushed back on questions about President Trump's stock trading, arguing that the bil...
Investors are weighing whether AMD can reach $600 this year as AI-driven demand and enterprise partnerships could lif...
As infrastructure spending gears up, industrial activity is priming the market for a new leg higher. Here are three s...
Ford’s stock closed at its highest level in three years, powered by AI tie-ups, improving European margins, and robus...
As Berkshire Hathaway prepares for a new era, Warren Buffett successor Greg Abel may be quietly orchestrating a bold,...
As the U.S. labor market tightens, veterans are increasingly finding a clear path into high-demand trades. This repor...
Champion Homes announces a definitive agreement to acquire the majority of Homes Direct assets, expanding its 95-stor...
A quiet day on the stock market today turned volatile for Boston Scientific after it reaffirmed full-year growth guid...